{
  "id": 2259821,
  "title": "How China Is Reshaping Big Pharma",
  "url": "https://urgent.news/2026/08/20/how-china-is-reshaping-big-pharma",
  "topic": "health",
  "section": "Health & Medicine",
  "published": "2026-08-20T23:01:01.000Z",
  "source": {
    "name": "Chiang Rai Times",
    "slug": "chiang-rai-times",
    "url": "https://www.chiangraitimes.com/china/how-china-is-reshaping-big-pharma/"
  },
  "original_language": "en",
  "account": null,
  "summary": "BEIJING – Roughly half of the new medicines entering human trials may now begin in Chinese laboratories, according to the figures discussed in the video. Western drugmakers aren’t waiting years to develop every replacement themselves. They are paying Chinese biotech companies for promising compounds, early trial data, and a head start. That shift matters because […] The post How China Is…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}